Hematopoietic Stem Cell Transplantation for Immunodeficiency, Part 2, An Issue of Immunology and Allergy Clinics, 1st Edition
Author :
By Chaim Roifman, MD, FRCPC, FCACB
This issue is part two of a two-part issue involving the emerging field of stem cell transplantation. Articles include: BMT for profound T cell Dysfunction (combined immunodeficiency); BMT and other management of HLA Class II deficiency; Genetic man
...view more
This issue is part two of a two-part issue involving the emerging field of stem cell transplantation. Articles include: BMT for profound T cell Dysfunction (combined immunodeficiency); BMT and other management of HLA Class II deficiency; Genetic manipulation of stem cells – Past and future; Gene therapy for ADA deficiency; Haemopoietic stem cell biology; and Indications for BMT.
This issue is part two of a two-part issue involving the emerging field of stem cell transplantation. Articles include: BMT for profound T cell Dysfunction (combined immunodeficiency); BMT and other management of HLA Class II deficiency; Genetic manipulation of stem cells – Past and future; Gene therapy for ADA deficiency; Haemopoietic stem cell biology; and Indications for BMT.
https://www.asia.elsevierhealth.com/hematopoietic-stem-cell-transplantation-for-immunodeficiency-part-2-an-issue-of-immunology-and-allergy-clinics-9781437718294.html306815Hematopoietic Stem Cell Transplantation for Immunodeficiency, Part 2, An Issue of Immunology and Allergy Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/https://www.asia.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png89.0998.99USDInStock/Medicine/Allergy & Clinical Immunology/Clinics/Clinics/Medicine/Allergy & Clinical Immunology/Japan Titles5054612505466652550415259900526316014886536505455351451205259833This issue is part two of a two-part issue involving the emerging field of stem cell transplantation. Articles include: BMT for profound T cell Dysfunction (combined immunodeficiency); BMT and other management of HLA Class II deficiency; Genetic manipulation of stem cells – Past and future; Gene therapy for ADA deficiency; Haemopoietic stem cell biology; and Indications for BMT. This issue is part two of a two-part issue involving the emerging field of stem cell transplantation. Articles include: BMT for profound T cell Dysfunction (combined immunodeficiency); BMT and other management of HLA Class II deficiency; Genetic manipulation of stem cells – Past and future; Gene therapy for ADA deficiency; Haemopoietic stem cell biology; and Indications for BMT.00add-to-cart97814377182942011 and earlierProfessionalBy Chaim Roifman, MD, FRCPC, FCACB20101Book152w x 229h (6.00" x 9.00")Saunders0Jun 17, 2010IN STOCKBy <STRONG>Chaim Roifman</STRONG>, MD, FRCPC, FCACBClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
